A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is an open-label, Phase 3, randomized, two arms, multicenter, prospective, experimental study of Folitime® (a new biosimilar formulation of r-hFSH, follitropin alfa) versus the original one (Gonal-f ®).
Epistemonikos ID: 187883a91e2bbf35ce2799bd8888312b079ee4a6
First added on: May 12, 2024